Safety And Efficacy Outcomes With A New Continuous-Range-Of-Vision Intraocular Lens
Published 2023 - 41st Congress of the ESCRS
Reference: FP32.11 | Type: Free paper | DOI: 10.82333/d5xc-3d60
Authors: Stephen Hannan 1 , David Teenan* 1 , Jan Venter 1 , Mirna Belovari 1 , Steven Dell 2 , Eric Donnenfeld 3
1Optical Express,Glasgow,United Kingdom, 2Ophthalmology, Cataract & Refractive Surgery,Dell Laser Consultants,Austin,United States, 3Ophthalmology,New York University Medical Centre,New York,United States
Purpose
To report on the safety and efficacy outcomes a new TECNIS Synergy premium IOL indicated for patients looking for an improved continuous-range-of- vision.
Setting
Private Refractive Surgery (Optical Express)
Methods
Outcomes of 755 presbyopic patients who underwent cataract surgery or refractive lens exchange with bilateral implantation of the TECNIS Synergy are reported. The age range of patients was 37 to 83 years, with pre-op refractive range of +11.00D to -11.25D and up to -3.50D of refractive astigmatism. Post-implant clinical safety and efficacy outcomes in addition to patient reported outcomes were analysed.
Results
Mean postoperative binocular distance visual acuity was +0.01 logMAR (range -0.18 to +0.60); intermediate visual acuity was 0.00 logMAR (range -0.30 to +0.58); and near visual acuity was +0.16 logMAR (range -0.18 to +0.60). The mean gain of lines for distance visual acuity was 4, lines gained of intermediate was 6 and 6 lines of near visual acuity. Twenty-two of the 1510 implanted eyes recorded >2 lines loss of BCDVA, 1.5%. Procedure recommendation rates are high. Adverse event rates with this premium IOL remain low.
Conclusions
The safety and efficacy outcomes for this new continuous-range-of-vision IOL confirms it may be a good option for patients looking for meaningful gains in uncorrected visual acuities at distant, intermediate, and near ranges. Longer follow- up is warranted to better understand the comparative performance of this IOL.